Lopez-Ferrer, A, Laiz, A, Puig, L. Psoriatic arthritis. MEDICINA CLINICA. 2022; 159(1)DOI:10.1016/j.medcli.2022.01.024. PMID:35525675. IF:3.900(Q2/4D).

Carrascosa, JM, Puig, L, Romero, IB, Salgado-Boquete, L, del Alcazar, E, Lencina, JJA, Moreno, D, de la Cueva, P. [Translated article] Practical Update of the Guidelines Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis With Biologic Agents: Part 2-Management of Special Populations, Patients With Comorbid Conditions, and Risk. Actas Dermo-Sifiliograficas. 2022; 113(6)DOI:10.1016/j.ad.2022.01.024. PMID:35748004. IF:(Q/D).

Tubau C., Amat-Samaranch V., Flores-Climente V.. Erythematous Facial Plaques With an Unfavorable Course. Actas Dermo-Sifiliograficas. 2022; 113(6)DOI:10.1016/j.ad.2021.01.013. PMID:. IF:(Q/D).

Thyssen J.P., Schuttelaar M.L.A., Alfonso J.H., Andersen K.E., Angelova-Fischer I., Arents B.W.M., Bauer A., Brans R., Cannavo A., Christoffers W.A., Crépy M.-N., Elsner P., Fartasch M., Filon F.L., Giménez-Arnau A.M., Gonçalo M., Guzmán-Perera M.G., Hamann C.R., Hoetzenecker W., Johansen J.D., John S.M., Kunkeler A.C.M., Hadzavdic S.L., Molin S., Nixon R., Oosterhaven J.A.F., Rustemeyer T., Serra-Baldrich E., Shah M., Simon D., Skudlik C., Spiewak R., Valiukeviciene S., Voorberg A.N., Weisshaar E., Agner T.. Guidelines for diagnosis, prevention, and treatment of hand eczema. CONTACT DERMATITIS. 2022; 86(5)DOI:10.1111/cod.14035. PMID:34971008. IF:5.500(Q1/1D).

Pereyra-Rodriguez J.-J., Herranz P., Figuras-Nart I., Perez B., Elosua M., Munera-Campos M., Melgosa-Ramos J., Zaragoza Ninet V., Silvestre J.F., Campos-Domínguez M., Guilabert A., Miquel J., Alcantara-Luna S., De La Cueva P., Serra-Baldrich E., Armario-Hita J.C.. Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort - Real Life: Fifty-Two-Week Follow-up Results. Dermatitis. 2022; 33(6)DOI:10.1097/DER.0000000000000958. PMID:36125777. IF:5.200(Q1/2D).

Richarz N.A., Boada A., Jaka A., Bassas J., Ferrándiz C., Carrascosa J.M., Yélamos O.. Challenges for New Adopters in Pre-Surgical Margin Assessment by Handheld Reflectance Confocal Microscope of Basal Cell Carcinoma; A Prospective Single-center Study. Dermatology Practical & Conceptual. 2022; 12(4)DOI:10.5826/dpc.1204a162. PMID:36534521. IF:2.800(Q2/4D).

Tubau C., Rusiñol L., Sánchez-Rodríguez G., Iznardo H., Amat-Samaranch V., Yélamos O.. Five Synchronous Melanomas: Role of Dermoscopy as a Triage Tool to Manage Melanoma During the COVID-19 Pandemic. Dermatology Practical & Conceptual. 2022; 12(4)DOI:10.5826/dpc.1204a209. PMID:36534517. IF:2.800(Q2/4D).

Reymundo A., Vilarrasa E., Baniandrés O., Rodríguez-Fernández-Freire L., Feltes R., Llamas-Velasco M., Daudén E.. Effectiveness and safety profile of secukinumab for the treatment of patients with generalized pustular psoriasis in daily practice. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2022; 36(10)DOI:10.1111/jdv.18317. PMID:35689497. IF:9.200(Q1/1D).

Escalé-Besa A., Fuster-Casanovas A., Börve A., Yélamos O., Fustà-Novell X., Rafat M.E., Marin-Gomez F.X., Vidal-Alaball J.. Using Artificial Intelligence as a Diagnostic Decision Support Tool in Skin Disease: Protocol for an Observational Prospective Cohort Study. Jmir Research Protocols. 2022; 11(8)DOI:10.2196/37531. PMID:. IF:(Q/D).

Bechman K., Cook E.S., Dand N., Yiu Z.Z.N., Tsakok T., Meynell F., Coker B., Vincent A., Bachelez H., Barbosa I., Brown M.A., Capon F., Contreras C.R., De La Cruz C., Meglio P.D., Gisondi P., Jullien D., Kelly J., Lambert J., Lancelot C., Langan S.M., Mason K.J., McAteer H., Moorhead L., Naldi L., Norton S., Puig L., Spuls P.I., Torres T., Urmston D., Vesty A., Warren R.B., Waweru H., Weinman J., Griffiths C.E.M., Barker J.N., Smith C.H., Galloway J.B., Mahil S.K.. Vaccine hesitancy and access to psoriasis care during the COVID-19 pandemic: findings from a global patient-reported cross-sectional survey. BRITISH JOURNAL OF DERMATOLOGY. 2022; 187(2)DOI:10.1111/bjd.21042. PMID:35104366. IF:10.300(Q1/1D).

Zachariae C., Mrowietz U., Strodl Andersen J., Puig L.. Multistate modelling of probability of on-treatment clinical response and time remaining in response in patients with moderate-to-severe psoriasis treated with brodalumab or ustekinumab in the AMAGINE-2 and -3 studies. EUROPEAN JOURNAL OF DERMATOLOGY. 2022; 32(4)DOI:10.1684/ejd.2022.4304. PMID:36301758. IF:2.500(Q2/5D).

Sánchez-Rodríguez G., Puig L.. Leishmaniasis and anti-TNF drugs. Piel. 2022; 37(6)DOI:10.1016/j.piel.2021.06.020. PMID:. IF:(Q/D).

Van Huizen A.M., Menting S.P., Gyulai R., Iversen L., Van Der Kraaij G.E., Middelkamp-Hup M.A., Warren R.B., Spuls P.I., Schejtman A.A., Egeberg A., Firooz A., Kumar A.S., Oakley A., Foulkes A., Ramos A.M.C., Fougerousse A.-C., Carija A., Akman-Karakas A., Horváth B., Fábos B., Matlock B.H., Claréus B.W., Castro C., Ferrándiz C., Correa C.C., Marchesi C., Goujon C., Gonzalez C., Maldonado-García C., Hong C.-H., Griffiths C.E.M., Vestergaard C., Echeverría C.M., De La Cruz C., Conrad C., Törocsik D., Drvar D.L., Balak D., Jullien D., Appelen D., Kim D.H., De Jong E.M.G.J., El Gamal E., Laffitte E., Mahé E., Sonkoly E., Colombo E.P., Vilarrasa E., Willaert F., Novoa F.D., Handjani F., Valenzuela F., Vílchez-Márquez F., Gonzalez G.O., Krisztián G., Damiani G., Krnjevic-Pezic G., Pellerano G., Carretero G., Hunter H.J.A., Riad H., Oon H.H., Boonen H.P.J., Moussa I.O., García-Doval I., Csányi I., Brajac I., Turchin I., Grozdev I., Weinberg J.M., Nicolopoulos J., Wells J., Lambert J.L.W., Ingram J.R., Prinz J.C., De Souza Sittart J.A., Sanchez J.L., Hsiao J.P.-F., Castro-Ayarza J.R., Maul J.-T., Van Den Reek J.M.P.A., Trcko K., Barber K., Reich K., Gebauer K.A., Khobzei K., Maul L.V., Massari L.P., Fardet L., Le Cleach L., Misery L., Chandrashekar L., Muresanu L.I., Lecluse L., Skov L., Frez M.L., Babic L.T., Puig L., Gomez L.C., Ramam M., Dutil M., El-Sayed M.H., Olszewska M., Schram M.E., Franco M.D., Llamas-Velasco M., Gonçalo M., Velásquez-Lopera M.M., Abad M.E., De Oliveira M.D.F.S.P., Seyger M.M.B., Kaštelan M., Rademaker M., Sikora M., Lebwohl M., Wiseman M.C., Ferran M., Van Doorn M., Danespazhooh M., Bylaite-Bucinskiene M., Gooderham M.J., Polic M.V., De Rie M.A., Zheng M., Gómez-Flores M., Salleras I Redonnet M., Silverberg N.B., Doss N., Yawalkar N., Chosidow O., Zargari O., De La Cueva P., Fernandez-Peñas P., Cárdenas Rojas P.J., Gisondi P., Grewal P., Sator P., Luna P.C., Félix P.A.O., Varela P., Holló P., Cetkovska P., Calzavara-Pinton P., Ghislain P.-D., Araujo R.R., Romiti R., Kui R., Ceovic R., Vender R., Lafuente-Urrez R.F., Del-Río R., Gulin S.J., Handa S., Mahil S.K., Kolalapudi S.A., Marrón S.E., Azimi S.Z., Janmohamed S.R., Da Cruz Costa S.A., Choon S.E., Urbancek S., Ayanlowo O., Margasin S.M., Wong T.-W., Mälkönen T., Hurtová T., Reciné T.R., Huldt-Nystrøm T., Torres T., Liu T.-Y., Leonidze T., Sharma V.K., Weightman W., Gulliver W., Veldkamp W.. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA Dermatology. 2022; 158(5)DOI:10.1001/jamadermatol.2022.0434. PMID:35353175. IF:10.900(Q1/1D).

Papp K.A., Thoning H., Gerdes S., Megna M., Brandi H., Jablonski Bernasconi M.Y., Yélamos O.. Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(7)DOI:10.1080/09546634.2022.2095330. PMID:35875991. IF:2.900(Q2/4D).

Puig L., Daudén E., Cuervas-Mons M., Novella C., Guisado C.. Persistence and effectiveness of guselkumab treatment in patients with moderate-to-severe plaque psoriasis in a non-interventional real-world setting: The SPRING study. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2025; 39DOI:10.1111/jdv.19403. PMID:37567861. IF:8.000(Q1/1D).

Armario-Hita JC, Carrascosa JM, Flórez Á, Herranz P, Pereyra-Rodríguez JJ, Serra-Baldrich E, Silvestre JF, Comellas M, Isidoro O, Ortiz de Frutos FJ. Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis From the Patient's Perspective: A Systematic Review. Dermatitis. 2024; 35(3)DOI:10.1089/derm.2023.0163. PMID:37751176. IF:3.200(Q1/2D).

Vilarrasa E, Camiña-Conforto G, Cabo F, Fernández-Vela J, Pousa M, Romaní J. Drainage setons for the management of sinus tracts in hidradenitis suppurativa.. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2024; 90(5)DOI:10.1016/j.jaad.2023.08.058. PMID:37634739. IF:11.800(Q1/1D).

Mateu-Arrom, LL, Puig, LL. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities. Expert Review of Clinical Pharmacology. 2024; 17(4)DOI:10.1080/17512433.2024.2340552. PMID:38603464. IF:3.000(Q2/4D).

Daudén, E, Escario, E, Martos-Cabrera, L, Armesto, S, Herrera-Acosta, E, Vidal, D, Vilarrasa, E, Rivera, R, de la Cueva, P, Martorell, A, Ballesca, F, Belinchón, I, Carretero, G, Rodríguez, L, Romero-Maté, A, Pujol-Montcusí, J, Salgado, L, Sahuquillo-Torralba, A, Coto-Segura, P, Baniandrés, O, Feltes, R, Riera-Monroig, J, Garrido, J, Llamas-Velasco, M. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(4)DOI:10.1111/ijd.16915. PMID:38168847. IF:3.200(Q1/3D).

Martí NR, Vilarrasa E, Llunell CL, Gamissans M, Sin M, Romaní J. Gluteal hidradenitis suppurativa: analysis of 83 patients [Hidradenitis supurativa con afectación glútea: análisis de 83 pacientes]. Actas Dermo-Sifiliograficas. 2024; 115(2)DOI:10.1016/j.ad.2023.09.021. PMID:37797882. IF:(Q/D).

Riera-Martí, N, Vilarrasa, E, López-Llunell, C, Gamissans, M, Sin, M, Romaní, J. Gluteal Hidradenitis Suppurativa: Analysis of 83 Patients. Actas Dermo-Sifiliograficas. 2024; 115(2)DOI:10.1016/j.ad.2023.11.003. PMID:38048948. IF:(Q/D).

Carmona-Rocha, E, Rusiñol, L, Puig, L. New and Emerging Oral/Topical Small-Molecule Treatments for Psoriasis. Pharmaceutics. 2024; 16(2)DOI:10.3390/pharmaceutics16020239. PMID:38399292. IF:5.500(Q1/1D).

Carmona-Rocha, E, Rusiñol, L, Yélamos, O. Painful flesh-coloured papules in a middle-aged woman. CLINICAL AND EXPERIMENTAL DERMATOLOGY. 2024; 49(6)DOI:10.1093/ced/llae007. PMID:38183665. IF:2.800(Q2/4D).

Alturo-Pons, A, Carmona-Rocha, E, Rusiñol, L, Iznardo, H, Puig, L. Pustules, arthritis, and fever in a patient with Crohn's disease. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(6)DOI:10.1111/ijd.17003. PMID:38183159. IF:3.200(Q1/3D).

Rusinol, L, Carmona-Rocha E., Puig L.. Durability and long-term outcomes of biologic therapies in psoriasis. Expert Review of Clinical Immunology. 2024; 20(1)DOI:10.1080/1744666X.2023.2250918. PMID:37610817. IF:3.700(Q2/5D).

Manzanares N., Vilarrasa E., López A., Alonso M.L., Velasco M., Riera J., del Alcázar E., Carrascosa J.M., Azón A., Rivera R., Santos S., Salgado-Boquete L., Roncero M., Dorado M., Yelamos O., Delgado C., Gallardo F., Ferran M.. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2024; 38(1)DOI:10.1111/jdv.19406. PMID:37561934. IF:8.000(Q1/1D).

Rusiñol, L, Puig, L. Multi-Omics Approach to Improved Diagnosis and Treatment of Atopic Dermatitis and Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(2)DOI:10.3390/ijms25021042. PMID:38256115. IF:4.900(Q1/3D).

Navarro-Bielsa A., Gracia-Cazaña T., Almagro M., De-la-Fuente-Meira S., Florez Á., Yélamos O., Montero-Vilchez T., González-Cruz C., Diago A., Abadías-Granado I., Fuentelsaz V., Colmenero M., Bañuls J., Arias-Santiago S., Buendía-Eisman A., Almenara-Blasco M., Gil-Pallares P., Gilaberte Y.. Exposome and basal cell carcinoma: a multicenter case–control study. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2024; 63(7)DOI:10.1111/ijd.17026. PMID:38282244. IF:3.200(Q1/3D).

Rusiñol, L, Mozos, A, Yélamos, O. Disseminated Monomorphic Pink Papules. JAMA Dermatology. 2023; 159(12)DOI:10.1001/jamadermatol.2023.3586. PMID:37938840. IF:11.500(Q1/1D).

Geat, D, Gisondi, P, Maurelli, M, Puig, L, Paul, C, Thaci, D, Iversen, L, Bellinato, F, Girolomoni, G. Price variability of TNF-a inhibitor biosimilars among European countries. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19756. PMID:38108512. IF:8.500(Q1/1D).

Sanz-Sánchez, T, Giménez-Arnau, AM, Mercader-García, P, Perez, RG, Zaragoza-Ninet, V, Miquel-Miquel, J, Silvestre-Salvador, JF, Córdoba-Guijarro, S, Carrascosa-Carrillo, JM, Gática-Ortega, ME, Ruíz-Gonzalez, I, Tous-Romero, F, Ortiz-de Frutos, FJ, Serra-Baldrich, E, Pastor-Nieto, A, Rodríguez-Serna, M, Sánchez-Pérez, J, Gilo, AS, Melé-Ninot, G, Guillén, PSP, García-Doval, I, Borrego, L. Sodium metabisulfite a current low relevant allergen in Spain. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19702. PMID:38088580. IF:8.500(Q1/1D).

Eyerich, K, Krueger, J, Stahle, M, Schakel, K, Conrad, C, Armstrong, A, Gniadecki, R, Puig, L, Scoble, T, Williams, N. An international Delphi consensus to define a clinically appropriate definition of disease modification for plaque psoriasis. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; DOI:10.1111/jdv.19652. PMID:38071690. IF:8.500(Q1/1D).

Segura S, Podlipnik S, Boada A, Martí RM, Sabat M, Yélamos O, Zarzoso-Muñoz I, Azón-Masoliver A, López-Castillo D, Solà J, Baliu-Piqué C, Galvany-Rossell L, Pasquali P, Just-Sarobé M, Duran X, Carrera C, Richarz NA, Pujol RM, Malvehy J, Puig S. Melanoma-specific survival in worse in the elderly: a multicentric cohort study.. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000923. PMID:37696262. IF:1.500(Q3/7D).

Carmona-Rocha, E, Sullivan, I, Yélamos, O. Vitiligo-like hypopigmentation induced by dabrafenib-trametinib: a potential marker for clinical response. MELANOMA RESEARCH. 2023; 33(6)DOI:10.1097/CMR.0000000000000918. PMID:37890183. IF:1.500(Q3/7D).

Blanco, G, López-Aventín, D, Pujol, RM, Gómez-Llonín, A, Puiggros, A, López-Sánchez, M, Estrach, T, García-Muret, MP, López-Lerma, I, Servitje, O, Bellosillo, B, Muro, M, Espinet, B, Rabionet, R, Gallardo, F. High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome. JOURNAL OF CLINICAL LABORATORY ANALYSIS. 2023; 37(23-24)DOI:10.1002/jcla.24982. PMID:38115685. IF:2.600(Q2/5D).

Pereyra-Rodriguez, JJ, Baldrich, ES, Ruiz-Villaverde, R, Torres, EB, Dobao, PD, Nart, IF, Menéndez, AF, Martin-santiago, A, Miquel, JM, Silvestre, JF, Armario-Hita, JC. Clinical Approach to Patients with Moderate-to-Severe Atopic Dermatitis: A Spanish Delphi Consensus. ACTA DERMATO-VENEREOLOGICA. 2023; 103DOI:10.2340/actadv.v103.12314. PMID:37982727. IF:3.500(Q1/3D).

Taleb, E, Yélamos, O, Ardigo, M, Christensen, RE, Geller, S. Non-invasive Skin Imaging in Cutaneous Lymphomas. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2023; 25(1)DOI:10.1007/s40257-023-00824-1. PMID:37964050. IF:8.600(Q1/1D).

Yosipovitch, G, Lio, PA, Rosmarin, D, Serra-Baldrich, E, Legat, FJ, Casillas, M, Pierce, E, Liu, ZQ, Sun, LN, Elmaraghy, H, Ständer, S. Lebrikizumab improved itch and reduced the extent of itch interference on sleep in patients with moderate-to-severe atopic dermatitis: two randomized, placebo-controlled, phase III trials. BRITISH JOURNAL OF DERMATOLOGY. 2023; 190(2)DOI:10.1093/bjd/ljad435. PMID:37939793. IF:11.000(Q1/1D).

Wollenberg A., Kinberger M., Arents B., Aszodi N., Barbarot S., Bieber T., Brough H.A., Pinton P.C., Christen-Zaech S., Deleuran M., Dittmann M., Fosse N., Gáspár K., Gerbens, LAA, Gieler U., Girolomoni G., Gregoriou S., Mortz C.G., Nast A., Nygaard U., Rehbinder E.M., Ring J., Rossi M., Roxburgh C., Serra-Baldrich E., Simon D., Szalai Z.Z., Szepietowski J.C., Torrelo A., Werfel T., Flohr C.. First update of the living European guideline (EuroGuiDerm) on atopic eczema. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 2023; 37(11)DOI:10.1111/jdv.19269. PMID:37328919. IF:8.500(Q1/1D).

Navarro-Bielsa, A, Gracia-Cazaña, T, Almagro, M, de la Fuente-meira, S, Flórez, A, Yélamos, O, Montero-Vilchez, T, González-Cruz, C, Diago, A, Abadías-Granado, I, Fuentelsaz, V, Colmenero, M, Bañuls, J, Arias-Santiago, S, Buendía-Eisman, A, Almenara-Blasco, M, Gil-Pallares, P, Gilaberte, Y. The Influence of the Exposome in the Cutaneous Squamous Cell Carcinoma, a Multicenter Case-Control Study. Cancers. 2023; 15(22)DOI:10.3390/cancers15225376. PMID:38001636. IF:4.500(Q1/3D).